After nearly a decade of development, Russia’s newest launch vehicle is close to its debut flight. The medium-lift Soyuz 5 rocket is expected to launch from the Baikonur Cosmodrome before the end of ...

Appeals court declines to reinstate order finding ‘probable cause exists’ to hold Trump officials in criminal contempt Kate Gosselin budgets Christmas for 8 kids 'to the penny' after losing reality TV ...

Jeff Bezos’ Blue Origin has landed the booster of its New Glenn mega-rocket on a drone ship in the Atlantic Ocean on just its second attempt — making it the second company to perform such a feat, ...

APART from the precious chance to live out my racing dreams, Toyota Motor Philippines (TMP) lent me the keys to a Toyota Corolla Altis 1.8 GR-S HEV (hybrid electric vehicle) to ferry me to the race ...

Asked how it felt to get his first big-league hit of the season, the Diamondbacks’ Jordan Lawlar didn’t even try to hold back a smile. “I’m not going to lie,” he said, “it felt pretty good.” Lawlar’s ...

AI-generated summary reviewed by our newsroom. Read our AI Policy. Altis at Serenity opens as a 220-acre 55-plus community near Fuquay Varina. Greenfield Communities cites increased demand among ...

Akshay Bhatia came so close to winning last time he played in Detroit, and he'll now get an opportunity to make up for his disappointing final round. After finishing as the runner-up in the 2024 ...

Attention is turning to major tokens as bitcoin BTC $89,274.20 set fresh highs earlier this week, with some pointing out that institutional demand and a clear regulatory environment pave the way for ...

Starbase is the site for Starship’s test launches. Jim Watson/AFP via Getty Images Elon Musk can now add a Texas city to the long list of ventures he’s juggling. Over the weekend, the SpaceX ...

This superfast propulsion system could aid humanity's exploration goals someday. When you purchase through links on our site, we may earn an affiliate commission. Here’s how it works. When it comes to ...

When AstraZeneca announced the results of its failed lung cancer immunotherapy trial in 2017, its stock plunged 16%. But that data was good for something — today, the drugmaker presented a ...